Hannes Schill, Managing Partner at eCAPITAL, says, "We have closely followed Apheris' journey since its inception and have been impressed by Apheris' technological advancements in federated computing. As cybersecurity investors, we recognise the growing importance of secure and private data collaboration, particularly in the life sciences sector where such capabilities can drive transformative outcomes."
Apheris facilitates secure data collaboration in life sciences. Founded in 2019 by Robin Röhm and Michael Höh, Apheris provides secure and governed access to data for AI and analytics, serving leading pharmaceutical companies such as Roche and Johnson & Johnson, as well as major hospitals.
According to Apheris, most healthcare data, around 97% per cent goes unused because it is stored separately by different organisations and can't be shared due to privacy and security concerns. This lack of access slows down progress in life sciences.
Apheris' Compute Gateway solves this problem by allowing secure data access and collaboration across organisations, thereby enabling pharmaceutical companies and healthcare providers to unlock the value of their IP-sensitive data while maintaining full control.
Collection
[
|
...
]